WallStreetZenWallStreetZen

NASDAQ: VTGN
Vistagen Therapeutics Inc Earnings & Revenue

VTGN past revenue growth

How has VTGN's revenue growth performed historically?
Company
N/A
Industry
82.48%
Market
19.08%
VTGN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
VTGN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

VTGN earnings and revenue history

Current Revenue
$1.1M
Current Earnings
-$29.4M
Current Profit Margin
-2,759.6%

VTGN Return on Equity

Current Company
-41.9%
Current Industry
16.8%
Current Market
28.2%
VTGN's Return on Equity (-41.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when VTGN announces earnings.

VTGN Return on Assets

Current Company
-37.6%
Current Industry
3.2%
VTGN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

VTGN Return on Capital Employed

Current Company
-24.77%
Current Industry
-42.4%
VTGN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

VTGN vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
VTGN$1.06M-$28.79M-$29.36M-28.60%N/A
PMVP$0.00-$64.02M-$65.10MN/AN/A
ASMB$0.00-$50.96M-$51.36M-100.00%N/A
COYA$6.13M-$9.55M-$10.30MN/AN/A
ALVR$0.00-$171.84M-$179.53MN/AN/A

VTGN earnings dates

Next earnings date
Jun 26, 2024

Vistagen Therapeutics Earnings & Revenue FAQ

What were VTGN's earnings last quarter?

On Invalid Date, Vistagen Therapeutics (NASDAQ: VTGN) reported Q1 2024 earnings per share (EPS) of -$0.25, up 85.21% year over year. Total Vistagen Therapeutics earnings for the quarter were -$9.52 million. In the same quarter last year, Vistagen Therapeutics's earnings per share (EPS) was -$1.69.

If you're new to stock investing, here's how to buy Vistagen Therapeutics stock.

What was VTGN's earnings growth in the past year?

As of Q2 2024, Vistagen Therapeutics's earnings has grown year over year. Vistagen Therapeutics's earnings in the past year totalled -$29.36 million.

What is VTGN's earnings date?

Vistagen Therapeutics's earnings date is Invalid Date. Add VTGN to your watchlist to be reminded of VTGN's next earnings announcement.

What was VTGN's revenue last quarter?

On Invalid Date, Vistagen Therapeutics (NASDAQ: VTGN) reported Q1 2024 revenue of $197.30 thousand up 12.17% year over year. In the same quarter last year, Vistagen Therapeutics's revenue was $175.90 thousand.

What was VTGN's revenue growth in the past year?

As of Q2 2024, Vistagen Therapeutics's revenue has grown null year over year. Vistagen Therapeutics's revenue in the past year totalled $1.06 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.